Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dimethyl fumarate treatment of primary progressive multiple sclerosis
2016-000283-41Phase 2Completed
- Sponsor
- Finn Sellebjerg
- Start
- Jun 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in primary progressive multiple sclerosis (PPMS) comparing Dimethyl fumarate with Placebo (2 arms). Started Jun 2016; status: completed.
02
Drugs
dimethyl fumarate
03
Conditions
primary progressive multiple sclerosis (PPMS)
Beyond the preview
Go deeper on 2016-000283-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-000283-41.